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Abstract Caspase-mediated proteolysis of cytoskeletal proteins
during apoptosis appears to be commonplace. Enlarging on
previous studies we have shown here that Q catenin, like L catenin,
was degraded during cisplatin-induced apoptosis, initially giving
a major product of 75 kDa. This truncated protein could be co-
immunoprecipitated with K catenin. Addition of caspase
inhibitors to cells in the presence of cisplatin appreciably reduced
the proteolysis of Q catenin as well as the level of apoptosis. Only
limited degradation of K catenin was observed even at very late
times when over 90% of cells in the culture were apoptotic.
Immunohistochemical staining showed that during apoptosis
there was a relocation of K, L and Q catenin from the periphery of
the cell to the cytoplasm, at the same time as other
morphological changes commonly associated with apoptosis
occurred. Interestingly, the changes in localisation of the catenins
preceded proteolysis by several hours. In the presence of cisplatin
and caspase inhibitor no change in distribution of catenins was
observed, suggesting that re-localisation requires caspase activity
but not necessarily directed against L and Q catenins.
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1. Introduction
Apoptosis is a process of fundamental importance for the
development and well-being of most, perhaps all, multi-cellu-
lar organisms. It plays a central role in normal morphogene-
sis, the functioning of the immune system and homeostasis
(reviewed, for example, in [1,2]). Detailed genetic analysis
has established the presence of a highly conserved set of reg-
ulators (both positive and negative) of apoptosis in organisms
as diverse as Caenorhabditis elegans and Homo sapiens with
functional and structural homologues being relatively wide-
spread in viruses (reviewed, for example, in [3^5]).
It appears that the principal e¡ectors of apoptosis are a
series of proteases (termed caspases) of the interleukin-1L-con-
verting enzyme (ICE) family [6^8]. The caspases, of which 10
have so far been identi¢ed in mammals, form a proteolytic
cascade such that certain components serve as substrates and
are thereby activated by caspases further up the cascade.
Thus, for example, caspase 10 cleaves pro-caspase 3, giving
active caspase 3 which can then degrade proteins such as
DNA-PK [9], protein kinase C D [10] and the retinoblastoma
protein (pRb) [11]. Cleavage sites for caspases share some
sequence homology with an absolute requirement for aspartic
acid at the P1 position. The requirements in the P2 to P4
positions seem to be dependent on the speci¢c caspase con-
cerned [8].
Over the past year it has become apparent that a very large
number of cellular components, including cytoskeletal pro-
teins, are degraded by caspases as apoptosis progresses.
Whilst the signi¢cance of much of this proteolysis remains
unclear at present it seems likely that degradation of cytoskel-
etal components is associated with the profound morpholog-
ical changes which occur during apoptosis. It has already been
demonstrated that L catenin serves as a substrate for caspase 3
leading to formation of a 65K fragment which has impaired
ability to bind K catenin [12]. This disruption of critical ad-
herens junction proteins was considered to be important for
loss of cell adhesion during apoptosis. Following on from
these studies by Brancolini et al. [12], we have shown the
caspase-mediated degradation of Q catenin in apoptotic hu-
man cells whilst K catenin remains una¡ected despite the pres-
ence of potential caspase cleavage sites. In addition, we have
shown that K, L and Q catenins are re-located within the cell
during the relatively early stages of apoptosis many hours
before protein cleavage is apparent. This re-location requires
caspase activity but presumably not directed against catenins.
2. Materials and methods
2.1. Cell lines
The Ad2 E1A+N-ras HER 313A cell line was produced by trans-
fection of adenovirus 2 early region 1A and mutant N-ras DNA into
human embryo retinoblasts (HER) as described [13]. Cells were nor-
mally maintained in HEPES-bu¡ered DME augmented with 8% FCS
and 2 mM glutamine. Additional cell lines used in some experiments
were: Ad12 E1A HLBRK3 produced by transfection of adenovirus 12
E1A DNA into hooded Lister baby rat kidney cells ; BJAB, an EBV-
negative B cell lymphoma cell line; Ramos, an EBV-negative Burkitt
lymphoma cell line and Jurkat, a T cell pro-lymphocytic leukaemia
cell line. Ad12 E1A HLBRK3 cells were grown on HEPES-bu¡ered
DME containing 8% FCS, whilst the remaining cell lines were grown
on RPMI containing 10% FCS and glutamine.
2.2. Apoptosis
Cells were usually induced to apoptosis by addition of cisplatin (15^
20 Wg/ml in the tissue culture medium). In some experiments apoptosis
was induced by treatment with UV light (300 J/m2). Caspases were
inhibited by the addition of Z-DEVD-FMK, Z-VAD-FMK, Z-
YVAD-FMK and Boc-Asp-FMK (all from Enzyme Systems Prod-
ucts), dissolved in DMSO, to the culture medium at a ¢nal concen-
tration of 40 WM.
2.3. Analytical methods
Western blotting: Cells were washed with cold saline, harvested by
aspiration and pelleted by centrifugation. Cells were solubilised in 9 M
urea, 50 mM Tris-HCl pH 7.4, 0.15 M L-mercaptoethanol and pro-
teins fractionated on 12% polyacrylamide gels run in the presence of
0.1 M Tris, 0.1 M Bicine, 0.1% SDS. Proteins were electrophoretically
transferred to nitrocellulose membranes which were incubated with
antibodies against K catenin, L catenin and Q catenin (all antibodies
obtained from Sigma). Antibodies against K catenin were raised in
rabbits and those against L and Q catenins were mouse monoclonals.
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Antibodies were diluted 1/4000, 1/4000 and 1/2000 for detection of K,
L and Q catenins respectively. Antigens were visualised by ECL (Amer-
sham).
Immunoprecipitation: Cells were washed with cold saline, harvested
by aspiration and pelleted by centrifugation. Cells were solubilised in
0.83 M NaCl, 1% NP40, 20 mM Tris-HCl pH 7.4, sonicated and
clari¢ed by centrifugation at 35 K for 30 min. Insoluble material
was discarded. Lysates containing equal amounts of protein were
pre-cleared by incubation with protein G-agarose (Sigma) for 30
min and then incubated with appropriate antibodies for 1 h. Anti-
body-antigen complexes were collected on protein G-agarose. After
appropriate washing immunoprecipitated proteins were fractionated
on 12% polyacrylamide gels and then subjected to Western blotting
as described above. Nitrocellulose ¢lters were probed with antibodies
against potential binding proteins which were visualised as described
above.
Acridine orange staining: Cell suspensions were mixed 1:1 with
acridine orange (10 Wg/ml) and then viewed by £uorescence micros-
copy after 5 min. The number of apoptotic cells in a sample of at
least 200 cells was counted.
2.4. Immunohistochemistry
Cells were grown on glass multiwell slides and were induced to
apoptosis by the addition of cisplatin (16 Wg/ml). Apoptotic and viable
cells were ¢xed in paraformaldehyde (4% in PBS) for 30 s and per-
meabilised with acetone at 320‡C (10 min). Fixed cells were stored at
320‡C. For staining, cells were thawed to room temperature and non-
speci¢c binding sites were blocked in blocking bu¡er (20% v/v heat
inactivated goat serum, 0.1% BSA w/v and 0.1% sodium azide in PBS)
for 30 min. Cells were immunostained by diluting the appropriate
antibody in the above blocking bu¡er (K catenin: 1/100, L catenin:
1/200 and Q catenin: 1/20). Cells were incubated for 90 min in a humid
box at 37‡C. The antibody was removed by washing the slides twice in
PBS for 15 min. FITC labelled anti-species antibody was diluted into
blocking bu¡er (1/40) before incubating for 60 min at 37‡C. Again the
antibody was removed by washing the slides twice in PBS for 15 min.
Nuclei were visualised by DAPI (10 WM) staining. The slides were
mounted in the presence of DABCO (2% 1,4-diazabicyclo-[2.2.2]oc-
tane in 80% glycerol/PBS). Cells were viewed by confocal microscopy
using a Zeiss Axiphot £uorescence microscope. Images were recorded
with the biovision software package (Impro Vision) and a low-light-
level video camera. The two channels were recorded independently
and pseudo-colour images generated and superimposed with Adobe
Photoshop 3.0 software.
3. Results
It is now well-established that a large number of cellular
proteins are substrates for caspases during apoptosis. Of par-
ticular interest has been the recent observation that cytoskel-
etal proteins such as lamin B [14], keratins [15], gelsolin [16]
and L catenin [12] are degraded as apoptosis occurs and that
this accompanies cytoskeletal reorganisation. With this in
mind we have examined the fate of other cytoskeletal compo-
nents and here describe the degradation of Q but not K cat-
enin.
3.1. L and Q but not K catenins are degraded during apoptosis
Ad2 E1A+N-ras HER 313A cells were induced to apoptose
by the addition of cisplatin. Cells were harvested at appropri-
ate times and subjected to SDS-PAGE and Western blotting.
It can be seen from the data presented in Fig. 1A that Q catenin
and L catenin were degraded as cells became more apoptotic
whilst K catenin was only slightly a¡ected, even at very late
times (Fig. 1B). Thus, at 16 h more than half of the L catenin
was cleaved (to give products of 75 kDa and 72 kDa) with
60% of the cells apoptotic by acridine orange staining. In the
set of samples Western blotted for Q catenin it can be seen that
at 16 h about 60% of the cells were apoptotic with about one
third of the protein degraded. In contrast K catenin was
cleaved to only a very limited extent 72 h after induction of
apoptosis, when over 90% of the cells were apoptotic (about
20% of the protein degraded).
The major cleavage product of L catenin was of 72 kDa
which is in reasonably close agreement to the ¢nal polypeptide
previously seen after caspase 3 action [12]. Degradation of
Q catenin only resulted in loss of a short polypeptide from
the protein ^ giving a reduction in molecular weight from
81 to 75 kDa (Fig. 1A). Patterns of Q catenin cleavage, iden-
tical to that shown in Fig. 1A, were observed when Ad12 E1A
HLBRK3, BJAB, Ramos and Jurkat cells were induced to
apoptose by the addition of cisplatin (20 Wg/ml) or when
Ad2 E1A+N-ras HER 313A and Ad12 E1A HLBRK3 cells
were treated with high doses of UV light (data not shown).
3.2. Inhibition of caspases
To con¢rm that proteolysis of Q catenin was directly linked
to cisplatin-induced apoptosis the e¡ects of di¡erent caspase
inhibitors were examined. All of the inhibitors used, with the
exception of Z-DEVD FMK (Fig. 2D), reduced appreciably
the extent of apoptosis over the 70 h time course of the experi-
ment. Even that inhibitor, although it did not greatly reduce
the ¢nal level of apoptosis, retarded the onset of cell death
such that at 8 and 18 h 3.6% and 47% respectively of cells
were identi¢ed as apoptotic compared with 35% and 78%
apoptotic cells (at 8 and 18 h) with cisplatin in the absence
of caspase inhibitors. As well as reducing the overall level of
apoptosis the caspase inhibitors appreciably reduced the pro-
teolytic breakdown of Q catenin. This is most marked with the
less speci¢c inhibitors Boc-Asp-FMK and Z-VAD-FMK (Fig.
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Table 1
Observed and predicted products of caspase-mediated proteolysis of catenins
Catenin Potential caspase cleavage sites Predicted products Observed product (from Fig. 1)
Predicted molecular weight
(Observed molecular weight [from Fig. 1])
K catenin aa 143^146 DMAD 15.5 kDa+84.5 kDa No observed degradation
100 kDa aa 500^503 DAVD 45 kDa+55 kDa
(94 kDa) aa 639^642 DDSD 70.5 kDa+29.5 kDa
L catenin aa 78^81 QVAD 8.5 kDa+77 kDa 75 kDa and 72 kDa
85.5 kDa aa 456^459 DRED 35.5 kDa+50 kDa
(88 kDa) aa 761^764 DLMD 2.5 kDa+83 kDa
Q catenin aa 693^696 DDMD 6 kDa+75.5 kDa 75 kDa
81.5 kDa aa 617^620 DAID 14 kDa+67.5 kDa
(81 kDa) aa 445^448 DKDD 33 kDa+48.5 kDa
K. Schmeiser et al./FEBS Letters 433 (1998) 51^5752
2B,C) which give a high degree of protection from protein
degradation. The inhibitor Z-DEVD-FMK did not inhibit
Q catenin breakdown as e⁄ciently as Boc-Asp-FMK or Z-
VAD-FMK but, as mentioned above, allowed apoptosis to
proceed to some extent. This may be explained by the limited
uptake of this inhibitor by cells in culture compared to other
inhibitors used here (C. Gregory, personal communication). It
can be seen from the Western blot in panel E that Z-YVAD-
FMK, whilst protecting cells from apoptosis does not stop
degradation of Q catenin as e¡ectively as the other com-
pounds. This may suggest that caspases 1 and 4 (for which
Z-YVAD-FMK is considered to be a relatively speci¢c inhib-
itor) are not directly involved in Q catenin breakdown. The
observation that Z-DEVD-FMK (Fig. 2D) limits degradation
of Q catenin at early times rather more e⁄ciently than Z-
YVAD-FMK may suggest the involvement of caspase 3
although this will have to await con¢rmation using puri¢ed
proteins.
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Fig. 1. Expression of catenins in apoptotic cells. Ad2 E1A+N-ras
HER 313A cells were treated with cisplatin (20 Wg/ml in the tissue
culture medium) and then harvested at times indicated. Percentage
apoptosis was determined by acidine orange staining and is shown
under the appropriate time point. Aliquots (containing 50 Wg of
protein) were fractionated on polyacrylamide gels and subjected to
Western blotting using antibodies against K catenin, L catenin and
Q catenin. The position of migration of marker proteins is shown on
the right-hand side of each panel and the calculated molecular
weights of catenins and their cleavage products on the left hand
side. A: Samples harvested over a 16 h time course. B: Samples
harvested over a longer time course and blotted for K catenin only.
Fig. 2. Inhibition of Q catenin cleavage and apoptosis with caspase
inhibitors. Ad2 E1A+N-ras HER 313A cells were treated with cas-
pase inhibitors (40 WM) and then with cisplatin (20 Wg/ml). Cells
were harvested at the indicated times and percentage apoptosis de-
termined by acridine orange staining. Aliquots (containing 50 Wg
protein) were subjected to Western blotting using antibody against
Q catenin. The position of migration of molecular weight markers is
shown. The following caspase inhibitors were used: A, no inhibitor;
B, Boc-Asp-FMK; C, Z-VAD-FMK; D, Z-DEVD-FMK; E, Z-
YVAD-FMK.
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3.3. Interaction of Q and K catenin in apoptotic cells
The interactions of K catenin with L and Q catenin are now
well-established. It has been shown that the 75 kDa L catenin
polypeptide formed by caspase activity is unable to bind to
K catenin and this has been suggested as a possible cause of
disruption of adherens junctions [12]. It would be expected
that the 75 kDa Q catenin product formed early in apoptosis
would still be able to interact with K catenin as the binding
site on Q catenin is between amino acids 109 and 137 [17]. To
test the validity of this suggestion K catenin from viable and
apoptotic Ad2 E1A+N-ras HER 313A cells was immunopre-
cipitated using the protocol described in Section 2. Bound
Q catenin was detected by Western blotting of these immuno-
precipitates (Fig. 3A). It can be seen that degradation prod-
ucts of Q catenin were precipitated with K catenin from apop-
totic cells, con¢rming the interaction. Uncleaved Q catenin
present in the apoptotic cells was also precipitated. When
L catenin was immunoprecipitated from apoptotic cell lysates
very little K catenin could be detected (Fig. 3B). Appreciable
K catenin could, however, be co-immunoprecipitated with
L catenin from viable cells.
3.4. Distribution of Q catenin in apoptotic cells
The morphological changes associated with apoptosis in
adherent mammalian cells have previously been carefully an-
alysed. There is a loss of cell-cell and cell-substratum contacts
as cells condense and form apoptotic bodies. Collapse of cy-
toskeletal networks formed by, for example, actin and vimen-
tin is marked such that the ¢lamentous distribution of the
proteins is lost with vimentin being concentrated in spherical
granules in apoptotic cells ([12] and our unpublished data). In
viable cells K and L catenins are normally present in adherens
junctions (containing catenin-cadherin complexes) at the cell
periphery playing a major role in cell-cell contacts. Staining
with antibodies against K and L catenin shows both proteins
concentrated primarily around the plasma membrane in viable
Ad2 E1A+N-ras HER 313A cells (Fig. 4A,E). However, treat-
ment with cisplatin leads to loss of staining of both proteins at
the cells periphery and their translocation to the cytoplasm as
discrete aggregates as cellular condensation and disruption of
the chromatin occurs (Fig. 4B^D,F^H). These changes are
readily apparent 3 h after addition of cisplatin (panels B
and F). Distribution of Q catenin in viable cells is somewhat
di¡erent to that seen for K and L catenin (Fig. 4A,E,I; Fig.
5A). Although there is some staining around the periphery of
the cell, presumably at the sites of attachment for intermediate
¢laments (desmosomes) and adherens junctions, a consider-
able proportion of the Q catenin appears as cytoplasmic gran-
ules which are predominantly perinuclear (Fig. 4I), possibly in
the endoplasmic reticulum (Fig. 5A). In the apoptotic cells
shown in Fig. 4J^L the Q catenin is further concentrated
into granules juxtaposed to the nuclei. Again, redistribution
of Q catenin is obvious within 3 h of cisplatin treatment (Fig.
4J). The cells shown in Fig. 4B,C,F,G,J,K have changed mor-
phology but few can be classi¢ed as apoptotic by acridine
orange staining (Fig. 1A). The cells shown in Fig. 4D,H,L
are, however, more obviously apoptotic as demonstrated by
acridine orange staining (Fig. 1A) and changes in the DAPI-
stained nuclei.
When Ad2 E1A+N-ras HER 313A cells were treated with
cisplatin in the presence of a caspase inhibitor (Z-VAD-FMK)
very little change in distribution of catenins was observed. At
10 h much of the Q catenin was still located around the cell
periphery (Fig. 5A,C). Z-VAD-FMK alone had no e¡ect on
cellular morphology (Fig. 5B). No change in distribution of
K and L catenins was observed when cells were treated with
cisplatin and Z-VAD-FMK (data not shown).
4. Discussion
It is now clear that morphological changes associated with
apoptosis are achieved through widespread disruption of the
cytoskeleton and that many cytoskeletal proteins are the sub-
strates for caspases (usually caspase 3). Recently, proteolytic
degradation by caspases of L catenin [12], cadherin (our un-
published data), keratins [15], vimentin ([15] and our unpub-
lished data), FAK [18] and actin [19] has been demonstrated.
Here we have shown that Q catenin serves as a further sub-
strate for caspases. The major product of caspase activity was
a polypeptide of about 75 kDa (Fig. 1). A potential caspase 3
cleavage site occurs in Q catenin between amino acids 693 and
696 (DDMD) which would give rise to a product similar in
size to that observed (Table 1). This motif contains an as-
partic acid residue at the P4 position which is considered to
be a requirement for caspase 3 cleavage. Indeed, it is worth
noting that there is slightly better inhibition of Q catenin pro-
teolysis at earlier (18 h) times by Z-DEVD-FMK (an inhibitor
of the caspase 3 family) than by the other caspase inhibitors.
However, it is not possible, on the basis of the in vivo inhib-
itor studies shown in Fig. 2, to reach any ¢rm conclusions as
to what caspases may be involved in the cleavage of a partic-
ular protein. Lack of speci¢city of the inhibitors and marked
di¡erences in uptake by cells preclude de¢nitive conclusions.
No further cleavage products of Q catenin were observed
after 3 days (Fig. 2 and data not shown), even though other
potential sites of caspase cleavage are present in the protein
(Table 1). However, there is a reduction in the level of the full-
length protein in the presence of caspase inhibitors Boc-Asp-
FMK and Z-VAD-FMK without a corresponding increase in
level of the 75K proteolytic product (seen in apoptotic cells
without inhibitor). This may be due to the production of
other polypeptides which are not recognised by the monoclo-
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Fig. 3. Co-immunoprecipitation of K and Q catenin. Ad2 E1A+N-
ras HER 313A cells were treated with cisplatin (20 Wg/ml) for 16 h.
Treated (apopototic) and untreated (viable) cells were harvested and
solubilised. Immunoprecipitation was carried out with antibodies
against K (A) and L (B) catenin (Sigma) as described. Immunopre-
cipitated proteins were fractionated by SDS-PAGE and then electro-
phoretically transferred to nitrocellulose membranes which were in-
cubated with antibodies raised against Q catenin (A) and K catenin
(B). Immunoprecipitated proteins are indicated. The position of mo-
lecular weight markers is shown. V, viable cells ; A, apoptotic cells.
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nal antibody (clone 15F11) used in these studies or to a wide-
spread proteolysis of the protein giving rise to very small
fragments. Removal of the N- or C-terminal domains from
Q catenin has recently been shown to a¡ect interactions with
other proteins, with the C-terminus regulating the lengths of
desmosomes [20]. It seems likely that the proteolysis of Q cat-
enin described here could play a role in disassembly of adher-
ens junctions, adhesive junctions and desmosomes. However,
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Fig. 4. Subcellular distribution of catenins in viable and apoptotic cells. Ad2 E1A+N-ras HER 313A cells were grown on multiwell slides, incu-
bated with cisplatin and then ¢xed with paraformaldehyde. Cells were stained for K catenin, L catenin or Q catenin (green) and for DNA with
DAPI (blue). Cells were viewed by confocal microscopy (see Section 2). A, E, I: Viable cells (not treated with cisplatin); B, F, J: treated with
cisplatin for 3 h; C, G, K: treated for 6 h; D, H, L: treated for 10 h. A^D: Stained for K catenin (green); E^H: stained for L catenin (green);
I^L: stained for Q catenin (green). (Magni¢cation objective U20.)
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loss of 47 amino acids from the C-terminus (or indeed a
comparably sized fragment from the N-terminus) would not
a¡ect binding to K catenin, the binding site for which has been
mapped to a region between amino acids 109 and 137 [17].
This has been con¢rmed by the co-immunoprecipitation data
presented in Fig. 3 where it can be seen that both full-length
and truncated Q catenin are precipitated in a complex with
K catenin. Notably caspase-mediated cleavage of L catenin
during apoptosis removes the K catenin binding site [12].
This is consistent with the data shown in Fig. 3B where there
is relatively little L catenin co-immunoprecipitated with the K
component. It is possible that caspase-mediated degradation
of L catenin in apoptotic cells is of major importance in the
disassembly of the adherens junctions, whilst proteolysis of
Q catenin plays a more central role in the fate of desmosomes
where K and L catenin are absent (reviewed, for example, in
[21]).
We have observed similar degradation of L catenin to that
reported earlier [12]. It is interesting, however, to note that
K catenin is largely una¡ected during apoptosis, even at very
late times (Fig. 1B). This is somewhat surprising as several
potential caspase cleavage sites exist within the protein (Table
1). It seems likely that factors other than the short tetrapep-
tide sequence must play a part in governing caspase-mediated
cleavage of some proteins during apoptosis.
The appreciable changes in localisation of the catenins seen
in Fig. 4 occur in the early stages of apoptosis (within 3 h)
when caspase-mediated degradation is not detectable (Fig.
1A). For example, the vast majority of L catenin and Q catenin
are still full-length at 10 h. In the presence of a caspase in-
hibitor no change in the location of the catenins was observed
(Fig. 5) with the distribution of the proteins being very similar
in viable cells and those treated, for 10 h, with cisplatin and
Z-VAD-FMK (Fig. 5 and data not shown). It seem likely
therefore that the disruption of adherens junctions and des-
mosomes and re-localisation of the catenins to the cytoplasm
does not require the proteolysis of appreciable amounts of
L and Q catenin within the cell. However, it is also clear that
caspase activity directed against, as yet, unidenti¢ed proteins
is essential for morphological change (Fig. 5). Determination
of the nature of these substrates will have to await further
investigation.
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